Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study. [PDF]
Oncol ResChuang CH +4 more
europepmc +1 more source
Incidence of childhood brain and other non-haematopoietic neoplasms near nuclear sites in Scotland, 1975-94. [PDF]
, 1999 Linda Sharp, P A McKinney, R.J. Black
openalex +1 more source
Retroperitoneal Neoplasm [PDF]
Proceedings of the Royal Society of Medicine, 1929 openaire +2 more sources
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Molecular Oncology, EarlyView.Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
Risk of malignancy of cytologic categories and post-biopsy clinical management of renal oncocytic neoplasms. [PDF]
Cancer CytopatholLin X.
europepmc +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
Molecular Oncology, EarlyView.CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Fallopian tube lavage sampling towards early detection of pre-invasive ovarian cancer. [PDF]
Clin Transl MedSeaton M +11 more
europepmc +1 more source
87P Enhancing treatment strategies for metastatic high-grade neuroendocrine neoplasms: Insights from extensive genomic profiling through WES and WGS in a phase I clinical setting [PDF]
S.K. Krogshede +10 more
openalex +1 more source